- 专利标题： Compounds for the treatment of hepatitis C
-
申请号： US12720182申请日： 2010-03-09
-
公开(公告)号： US08293909B2公开(公告)日： 2012-10-23
- 发明人: Richard Pracitto , John F. Kadow , John A. Bender , Brett R. Beno , Katharine A. Grant-Young , Ying Han , Piyasena Hewawasam , Andrew Nickel , Kyle E. Parcella , Kap-Sun Yeung , Louis S. Chupak
- 申请人： Richard Pracitto , John F. Kadow , John A. Bender , Brett R. Beno , Katharine A. Grant-Young , Ying Han , Piyasena Hewawasam , Andrew Nickel , Kyle E. Parcella , Kap-Sun Yeung , Louis S. Chupak
- 申请人地址： US NJ Princeton
- 专利权人： Bristol-Myers Squibb Company
- 当前专利权人： Bristol-Myers Squibb Company
- 当前专利权人地址： US NJ Princeton
- 代理商 James Epperson
- 主分类号： C07D471/04
- IPC分类号： C07D471/04 ; A61K31/437
摘要：
The disclosure provides compounds of formula I, II, III, IV, and V, including their salts, as well as compositions and methods of using the compounds. The compounds have activity against hepatitis C virus (HCV) and may be useful in treating those infected with HCV.
公开/授权文献
- US20100184800A1 Compounds for the Treatment of Hepatitis C 公开/授权日：2010-07-22
信息查询
